Root Cause Analysis Investigation Report. Clostridium Difficile Ian Monro Ward. The Royal National Orthopaedic Hospital

Size: px
Start display at page:

Download "Root Cause Analysis Investigation Report. Clostridium Difficile Ian Monro Ward. The Royal National Orthopaedic Hospital"

Transcription

1 Root Cause Analysis Investigation Report Clostridium Difficile Ian Monro Ward The Royal National Orthopaedic Hospital CONTENTS Incident description and consequences Pre-investigation risk assessment Background and context Terms of reference The investigation team Scope and level of investigation Investigation type, process and methods used Involvement and support of patient and relatives Involvement and support provided for staff involved Information and evidence gathered Chronology of events Detection of incident Notable practice Care and service delivery problems Contributory factors Root causes Lessons learned Recommendations Arrangements for shared learning Distribution list Appendices MAIN REPORT Incident description and consequences This 48yr old female was admitted into the Royal National Orthopaedic Hospital (RNOH) on the Private Patient Unit (PPU) on the 14 th March 2012 under the care of Mr Nejad for revision right total hip replacement. The patients past medical history is as follows: Bi lateral DDH Various osteotomy of right and left hip Removal of metalwork left hip 2011 Right uncemented total hip replacement 2000 Left hip arthrogram 2011 At RNOH the patient was sent to theatre on the 14 th March The patient was received back onto the ward at The patient had no bowel movement on that day. The patient was given Prophylaxis antibiotics, three doses of iv cefuroxime 750mg as follows: 14/03/12 at /03/12 at /03/12 at 03.20

2 15/03/12 bowels opened, no concerns reported. 16/03/12 temperature raised to 38.5 C bowels opened large motion slightly soft stool. 17/03/12 had 3 x loose stool motion, sample sent to microbiology. The patient was already in a side room with single bathroom; barrier nursing and infection control precautions were initiated immediately. Diclofenac was omitted it was causing the patient stomach irritation and nausea. It is documented that the patient had one episode of loose offensive stool at /03/12 Patient had 2 x loose stools, was seen by SHO at and he confirmed that the stool sample had tested positive of Clostridium Difficile (CDI). Stool chart (based on the Bristol stool chart) was commenced and the patient was started on 500mg metronidazole three times a day as prescribed. The first dose was given at 16.00hrs. The Patient was then given advice on C.difficile by the medical team. Patient vomited after taking metronidazole anti emetics given before further doses with good effect. 19/03/12 actimel commenced at as prescribed on dietician advice by the medical team. Patient continued to have Loose stools x 5. Repeat stool sample was sent and Metronidazole dose was changed to 400mg three times daily. 20/03/12 had 2 x small episodes of loose stools and vomited once. Seen by microbiologist and infection control for review and further information regarding the infection was given. 21/03/12 had 4 x episodes of loose stools, small amount and one episode of formed stool at Seen by SHO who told patient she can go home on Thursday 22/03. No loose stools overnight into the 22/03. 22/03/12 Seen by Mr. Nejad who confirmed patient can go home. Advice given to patient on infection control procedures regarding C Diff, Infection control nurse was informed that the patient had requested a leaflet for information regarding C Diff. Patient sent home to continue with a ten day course of antibiotics and was discharged from ward. Incident date: 18 th March 2012 Incident type: Specialty: Patient confirmed with Clostridium difficile Infection (CDI) by stool sample results Private Patient Unit (Ian Munro ward) Effect on patient: Patient was lacking energy, felt nauseated and was upset with the whole situation. Severity level: severe Pre-investigation risk assessment A Potential Severity (1-5) B Likelihood of recurrence at that severity (1-5) C Risk Rating (C = A x B) Background and context The investigation was undertaken using the Root Cause Analysis (RCA) toolkit. The toolkit provided a framework to ensure that relevant facts and information were collected. The purpose of the investigation is not to apportion blame but to be able to reflect on this case to establish if there was anything which the organisation could have done to prevent this case of C.difficile.

3 The investigation team Georgina Whorlow Staff Nurse PPU Michelle Bozier Ward sister PPU Zama Khumalo Infection Control Nurse Scope and level of investigation An investigation was undertaken by the investigators employed by the RNOH. This investigation and the results will be shared with the Infection Control Committee, Clinical Governance, the Clinical Risk Outcome Panel and the Clinical Quality Review Meeting held by Commissioners. Investigation type, process and methods used The investigation team met twice to review the medical nursing notes and to discuss the case. Involvement and support of patient and relatives The patient was seen by Dr Mack the microbiologist consultant from the Royal Free Hospital but was not involved in the process of this investigation. Involvement and support provided for staff involved The senior staff and the Infection Control Link will feed back the findings of the investigation of the RCA locally to all staff. Training issues identified will be addressed. Information and evidence gathered The patient s medical and nursing notes were used. Telephone calls to Microbiology department for more information. Chronology of events At RNOH the patient was sent to theatre on the 14 th March The patient was received back onto the ward at The patient had no bowel movement on that day. The patient was given Prophylaxis antibiotics, three doses of iv cefuroxime 750mg as follows: 14/03/12 at /03/12 at /03/12 at /03/12 bowels opened, no concerns reported. 16/03/12 temperature raised to 38.5 C bowels opened large motion slightly soft stool. 17/03/12 had 3 x loose stool motion, sample sent to microbiology. The patient was already in a side room with single bathroom; barrier nursing and infection control precautions were initiated immediately. Diclofenac was omitted it was causing the patient stomach irritation and nausea. It is documented that the patient had one episode of loose offensive stool at /03/12 Patient had 2 x loose stools, was seen by SHO at and he confirmed that the stool sample had tested positive of Clostridium Difficile (CDI). Stool chart (based on the Bristol stool chart) was commenced and the patient was started on 500mg metronidazole three times a day as prescribed. The first dose was given at 16.00hrs. The Patient was then given advice on C.difficile by the medical team. Patient vomited after taking metronidazole anti emetics given before further doses with good effect. 19/03/12 actimel commenced at as prescribed on dietician advice by the medical team. Patient continued to have loose stools x 5. Repeat stool sample was sent and Metronidazole dose was changed

4 to 400mg three times daily. 20/03/12 had 2 x small episodes of loose stools and vomited once. Seen by microbiologist and infection control for review and further information on regarding the infection was given. 21/03/12 had 4 x episodes of loose stools, small amount and one episode of formed stool at Seen by SHO who told patient she can go home on Thursday 22/03. No loose stool s overnight into the 22/03. 22/03/12 Seen by Mr. Nejad who confirmed patient can go home. Advice given to patient on infection control procedures regarding C Diff, Infection control nurse was informed that the patient had request a leaflet for information regarding C Diff. Patient sent home to continue with a ten day course of antibiotics and was discharged from ward. Detection of incident: 18/03/12 at SHO informed the ward and the patient of stool sample results. Notable practice 1. As soon as diarrhoea was evident a stool sample was sent and patient was barrier nursed. Patient was already in a single room with a single bathroom in it. 2. Infection control nurse was informed immediately. 3. A stool sample was collected and sent as soon as it was possible to do so. 4. Hand hygiene using soap and water was reinforced. 5. A nurse was designated to look after the patient to try and lesson the amount of traffic into the isolation room and therefore prevent possible cross contamination associated with carpets. 6. Theatre disposable shoe covers were used in order to prevent the spread of spores. 7. Patient was barrier nursed for entirety of stay by one nurse who had no other patient caseload, 8. Advice gained as to whether there was any disposable footwear the ward could use as entering the patients room on carpet and then re entering the ward. No disposable footwear found. 9. Physiotherapists saw the patient last on their daily list. Care and service delivery problems 1. Having a single nurse from the ward to look after the patient could have led to issues with staffing levels. 2. Only one episode of loose stool was indicated as being offensive so second sample was sent however this was not labelled correctly. 3. Difficult to effectively decontaminate the isolation room because of carpet flooring. Contributory factors 1. Antibiotic treatment Iv cefuroxime 750 mg 14/03/12 at /03/12 at /03/12 at Query medical treatment in French hospital and in Bushy Spires but no dates nor antibiotic usage is documented.

5 Root causes 1. Use of broad spectrum antibiotics Lessons learned: Recommendations Education and training to reinforce use of the Bristol stool chart. Education and training on C.difficile. Give patient Information leaflets on C.difficile. Label samples as per protocol Audit hand hygiene compliance within the ward at least weekly when there is a Patient with C.difficile /diarrhoea. In order to maintain constant C.difficile awareness the Trust must continue to reinforce vigilance and awareness of risks that are associated with C Diff and to promote antimicrobials stewardship Disposable footwear for PPU could be implemented for infected patients or have the carpets removed. Arrangements for shared learning The report will be reviewed and an action plan will be implemented and monitored by the Clinical Governance Committee. Ward education regarding infection control and liaise with the infection control nurse regarding training. Distribution list Infection Control Committee Clinical Governance Committee. Clinical Risk Outcome Panel Appendices Author Georgina Whorlow Michelle Bozier Zama Khumalo Job title Staff Nurse Ward sister ICN Date 02/05/ /05/12

6 Appendix 1 RCA Tools Templates Fishbone Patient factors: History of having received various treatment in France and in Bushy but no documentation on antibiotics usage Staff factors: Nil identified Task factors: Nil identified Communication factors: No documented history of previous antibiotic usage for patient Team + social factors: A nurse had to be designated to look after the affected patient Problem or issue C.difficile infection on a generally healthy patient Education + Training Factors: Use of the Bristol stool chart. Information about C. difficile to patients and staff. Equipment + resources: Decontamination issues as the room is carpeted Working condition factors: Designating a single nurse to one to one the patient affected staffing levels on the ward Organisational + strategic factors: Use of cefuroxime x 3 doses for prophylaxis as main cause of CDI

7 Appendix 2 ROOT CAUSE ANALYSIS ACTION PLAN Clostridium Difficile on Ian Monro Ward Risk Description Use of iv cefuroxime X 3 doses for prophylaxis. Controls Currently In Place Antimicrobials policy Royal Free Hospital Infection Service Consequ ence (C ) 1 Insignific ant 2 Minor 3 Moderate 4 Major 5 Catastrop hic Likelihoo d (L) 1 Rare 2 Unlikely 3 Possible 4 Likely 5 Almost Certain Risk Rating (C X L) 5 4 High Action Description The Trust has to make an informed decision on antibiotic prophylaxis i.e.use of iv cefuroxime X 3 doses for prophylaxis must be urgently reviewed. Start Date 2012 Anticipated Date Of Completion June 2012 Designated Lead DIPC Risk Rating after actions complete ( C X L including score) 5x 4 = 20 Progress Action Taken For each action state whether it is: Completed Ongoing To be discussed in relevant committees. July 12 Discussed at The antibiotic of choice must be effective but less likely to predispose patients to C.difficile infection. Continue to promote antimicrobials stewardship constantly Ongoing Pharmacy/ Microbiology / ICN Ongoing Audit usage of antimicrobials at RNOH 2012 Not yet complete Pharmacy/ Microbiology In progress

8 Formulate Antimicrobials Steering Group Jan 2012 Not yet complete Pharmacy/ Microbiology/ DIPC Environmental Decontamination issues. Affected patient was in a carpeted isolation room High risk of infection spread (C.difficile spores) which could have resulted in cross Contamination and possible outbreak Cleaning and decontamination policy, DH guidance 4 4 High Carpets are a great infection control risk and must removed from all clinical areas and be replaced with washable flooring Director of estates and facilities, the ICC, DIPC 4x 4 = 16 The issue of carpets has been highlighted with the DIPC, and health and safety committees. Promote constant awareness on issues related to C.difficle Training and education 3 3 Moderate Continuous Training and education of staff on these issues and aim to achieve sustained compliance. Reinforce use of stool charts as well as Bristol stool charts and proper stool sample collection and labelling ICN/Micro 3x 3 = 9 Staff and patient information leaflets and posters are now available across RNOH. Annual update training session on various IC topics including C.difficile is ongoing. Adhoc training at ward level is arranged with the ICN as necessary.

Root Cause Analysis Investigation Report. The Royal National Orthopaedic Hospital

Root Cause Analysis Investigation Report. The Royal National Orthopaedic Hospital Root Cause Analysis Investigation Report The Royal National Orthopaedic Hospital Root Cause Analysis on a case of Clostridium Difficile on Margaret Harte March 2012 CONTENTS Incident description and consequences

More information

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13 Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire

More information

Checklists for Preventing and Controlling

Checklists for Preventing and Controlling Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,

More information

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST).

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST). Airedale NHS Foundation Trust Board of Directors: 27 February 2013 Title: Update on Actions to Reduce the Incidence of Clostridium difficile at Airedale NHS Foundation Trust Author: Allison Charlesworth,

More information

Includes GP flow chart & out of hours protocols. Page 1 of 11

Includes GP flow chart & out of hours protocols. Page 1 of 11 Clostridium Difficile Policy. Precautions to be observed when caring for ECCH in-patients colonised or infected with Clostridium Difficile (C.difficile) Includes GP flow chart & out of hours protocols

More information

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP

More information

HCAI Local implementation team action plan

HCAI Local implementation team action plan HCAI Local implementation team action plan Item Type Report Authors New Governance HCAI Group Publisher New Governance HCAI Group Download date 16/09/2018 18:12:09 Link to Item http://hdl.handle.net/10147/110814

More information

Protocol for the Prevention and Management of Clostridium difficile.

Protocol for the Prevention and Management of Clostridium difficile. Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection

More information

Infection Control Care Plan. Patient Demographic / label. Hospital: Ward:

Infection Control Care Plan. Patient Demographic / label. Hospital: Ward: Patient Demographic / label Infection Control Care Plan for a patient with loose stools of unknown origin Statement: This care plan should be used with patients who have loose stools of unknown origin.

More information

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 Background Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 The C.difficile objective for EKHUFT in 2013 2014 was 29 cases and in April 2013, the

More information

Guideline for the Management of Patients with Known or Suspected Diarrhoea / Viral Gastroenteritis

Guideline for the Management of Patients with Known or Suspected Diarrhoea / Viral Gastroenteritis Guideline for the Management of Patients with Known or Suspected Diarrhoea / Viral Gastroenteritis 1. Introduction 1.1 Patients with diarrhoea pose a risk to other patients from micro-organisms contaminating

More information

Clostridium difficile policy

Clostridium difficile policy Clostridium difficile policy Document level: Trustwide (TW) Code: IC5 Issue number: 4 Lead executive Director of Infection, Prevention and Control Author and contact number Infection Prevention and Control

More information

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland V2.0 November 2011 A CDI Trigger is the point at which the Infection

More information

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI

More information

CoG (04/17) Item 19. Council of Governors. Item for Information. C difficile Action Plan. To note the report. DATE 11 April 2017 REPORT FOR SUBJECT

CoG (04/17) Item 19. Council of Governors. Item for Information. C difficile Action Plan. To note the report. DATE 11 April 2017 REPORT FOR SUBJECT CoG (04/17) Item 19 DATE 11 April 2017 REPORT FOR Council of Governors SUBJECT Item for Information TITLE C difficile Action Plan BACKGROUND DOCUMENT (IF ANY) EXECUTIVE COMMENT (INCLUDING KEY ISSUES OF

More information

Influence of Patient Flow on Quality Care

Influence of Patient Flow on Quality Care Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)

More information

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance

More information

Investigating Clostridium difficile Infections

Investigating Clostridium difficile Infections CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Investigating Clostridium difficile Infections Erin P. Garcia, MPH, CPH Healthcare-Associated Infections (HAI) Program Center for Health Care Quality California Department

More information

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE

More information

Infection Prevention and Control Annual Report 2012/13

Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 1 Contents 1. Executive Overview 2. Key Achievements 3. Infection Prevention and Control Team

More information

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards HEI self-assessment Completing the self-assessment - Guidance to NHS boards INTRODUCTION This document should be read in conjunction Healthcare Improvement Scotland healthcare associated infection (HAI)

More information

PATIENTS WITH DIARRHOEA

PATIENTS WITH DIARRHOEA PATIENTS WITH DIARRHOEA Infection Prevention and Control Policy: Document Author Written By: Infection Prevention & Control Team Date: September 2015 Lead Director: Executive Directorate of Nursing Authorised

More information

Influence of Patient Flow on Quality Care

Influence of Patient Flow on Quality Care Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District

More information

Infection Prevention and Control Strategy (NHSCT/11/379)

Infection Prevention and Control Strategy (NHSCT/11/379) Infection Prevention and Control Strategy (NHSCT/11/379) September 2010 September 2010 Contents Page No. 1. Foreword 1 2. Introduction 2-3 3. Key Principles 4-5 4. Objectives 6-13 5. Organisational Arrangements

More information

Infection Prevention and Control Annual Report 2015/16

Infection Prevention and Control Annual Report 2015/16 Infection Prevention and Control Annual Report 2015/16 Amanda Hemsley, Senior Nurse Advisor for Infection Prevention and Control Report Period: April 2015 March 2016 Report Date: June 2016 Infection Prevention

More information

Developed in response to: Best Practice Infection Prevention and Control

Developed in response to: Best Practice Infection Prevention and Control Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical

More information

Management of Patients with Diarrhoea

Management of Patients with Diarrhoea Management of Patients with Diarrhoea Reference No: Version: 1 Ratified by: G_IPC_45 LCHS Trust Board Date Ratified: 12 th January 2016 Name of originator/author: Name of responsible committee/individual:

More information

INFECTION PREVENTION & CONTROL. ANNUAL REPORT Northern Devon Healthcare NHS Trust

INFECTION PREVENTION & CONTROL. ANNUAL REPORT Northern Devon Healthcare NHS Trust INFECTION PREVENTION & CONTROL ANNUAL REPORT 2013-14 Northern Devon Healthcare NHS Trust incorporating community services in Exeter, East and Mid Devon 1 Kevin Marsh David Richards Joint Directors of Infection

More information

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative Patient information Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative i Important information for all patients. Golden Jubilee National Hospital Agamemnon Street Clydebank, G81

More information

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

Guidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015

Guidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015 Guidelines for the Management of C. difficile Infections in Healthcare Settings Saskatchewan Infection Prevention and Control Program November 2015 Agenda What is C. difficile infection (CDI)? How do we

More information

Infection Prevention & Control Annual Report 2011/2012

Infection Prevention & Control Annual Report 2011/2012 Infection Prevention & Control Annual Report 2011/2012 Board of Directors Approval date: 1 November 2012 Infection Prevention & Control Committee Submission date: 1 August 2012 Position at 31 March 2012

More information

Outbreak Management Policy

Outbreak Management Policy Policy No: IC24 Version: 5.0 Name of Policy: Outbreak Management Policy Effective From: 13/09/2012 Date Ratified 27/07/2012 Ratified Infection Prevention & Control Committee Review Date 01/07/2014 Sponsor

More information

Outbreak Management 2015

Outbreak Management 2015 Outbreak Management 2015 Learning Outcomes For staff to be able to Define an outbreak To recognise an outbreak Identify the actions to be taken when an outbreak occurs Implement specific actions to be

More information

abc INFECTION CONTROL STRATEGY

abc INFECTION CONTROL STRATEGY abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems

More information

New document. Reviewed document

New document. Reviewed document Title Guideline reference number Aim and purpose of clinical document Infection Control Policy for the Prevention and Management of Primary Care Acquired Clostridium difficile Associated Diarrhoea. 008

More information

Commissioning for Quality & Innovation (CQUIN)

Commissioning for Quality & Innovation (CQUIN) Commissioning for Quality & Innovation () The following suite of s are goals relating to improvements in the quality of patient care which the Trust has agreed with commissioners (with the exception of

More information

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION IFF IFF DIFF. DIFF C. DIFF FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION Information for patients, their families and carers. What does it mean if someone has Clostridium difficile, or C. diff? These

More information

Establishing an infection control accreditation programme to control infection

Establishing an infection control accreditation programme to control infection International Journal of Infection Control www.ijic.info ISSN 1996-9783 Establishing an infection control accreditation programme to control infection Julie Parker Sheffield Teaching Hospitals NHS Foundation

More information

NLG(13)250. DATE 30 July Trust Board of Directors Part A. Dr Liz Scott, Medical Director REPORT FROM

NLG(13)250. DATE 30 July Trust Board of Directors Part A. Dr Liz Scott, Medical Director REPORT FROM NLG(13)250 DATE 30 July 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Dr Liz Scott, Medical Director CONTACT OFFICER Dr Liz Scott, Medical Director SUBJECT Infection Control Committee Minutes

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

Frequently Asked Questions. (Version # 3-November 2014)

Frequently Asked Questions. (Version # 3-November 2014) MSH-UHN First Episode C.difficile (CDI) Management Algorithm 1) Why was this algorithm developed? Frequently Asked Questions (Version # 3-November 2014) In a review of UHN and MSH data, we found that one

More information

CLOSTRIDIUM DIFFICILE INFECTION PREVENTION AND CONTROL POLICY

CLOSTRIDIUM DIFFICILE INFECTION PREVENTION AND CONTROL POLICY CLOSTRIDIUM DIFFICILE INFECTION PREVENTION AND CONTROL POLICY (to be read in conjunction with all other Trust Infection Prevention and Control Policies) Version: 4 Date issued: August 2015 Review date:

More information

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in

More information

Progress Report on C.Diff Action Plan

Progress Report on C.Diff Action Plan NHS GREATER GLASGOW AND CLYDE NHS Board Meeting 16 December 2008 Paper No. 08/55 Board Medical Director Progress Report on C.Diff Action Plan Recommendation The NHS Board is asked to receive this further

More information

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights

More information

POLICY FOR TAKING BLOOD CULTURES

POLICY FOR TAKING BLOOD CULTURES Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)

More information

CLOSTRIDIUM DIFFICILE ACTION PLAN

CLOSTRIDIUM DIFFICILE ACTION PLAN CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE

More information

MRSA: National developments, Progress, Challenges and Targets

MRSA: National developments, Progress, Challenges and Targets MRSA: National developments, Progress, Challenges and Targets Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London The MRSA challenge - 2007 Bacteraemia

More information

Healthcare associated infections across the health and social care community

Healthcare associated infections across the health and social care community Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it

More information

Infection Prevention and Control Outbreak Policy

Infection Prevention and Control Outbreak Policy Infection Prevention and Control Outbreak Policy IPCT Outbreak Policy V3, Lead Nurse IPC, November 2016 Page 1 Policy Title: Outbreak Policy Executive Summary: This policy details the actions to be followed

More information

Hospital Outbreak Management Policy

Hospital Outbreak Management Policy Hospital Outbreak Management Policy Version Number 3 Version Date June 2016 Owner Author First approval or date last reviewed Staff/Groups Consulted Director of Infection Prevention and Control Nurse Consultant

More information

Arrangements. Version 10

Arrangements. Version 10 UNIQUE IDENTIFIER NO: C-64-2014 Nurse Section A - Arrangements Version 10 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or

More information

Policy for Control of Diarrhoea and Vomiting due to Norovirus. Vickie Longstaff (Infection Control Nurse Consultant) Version 5

Policy for Control of Diarrhoea and Vomiting due to Norovirus. Vickie Longstaff (Infection Control Nurse Consultant) Version 5 Policy for Control of Diarrhoea and Vomiting due to Norovirus Author(s) Vickie Longstaff (Infection Control Nurse Consultant) Version 5 Version Date May 2013 Implementation/approval Date May 2013 Review

More information

The safety of every patient we care for is our number one priority

The safety of every patient we care for is our number one priority HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally

More information

Infection Prevention and Control. Quarterly Report

Infection Prevention and Control. Quarterly Report Infection Prevention and Control Quarterly Report 1 st July 2009 30 th September 2009 Dr Nick Harper Director of Infection Prevention and Control Mrs Johanne Lickiss Nurse Consultant Infection Prevention

More information

Infection Control Performance Improvement Quality Assurance & Performance Improvement (QAPI) Case Study

Infection Control Performance Improvement Quality Assurance & Performance Improvement (QAPI) Case Study Infection Control Performance Improvement Quality Assurance & Performance Improvement (QAPI) Case Study Happy Acres Nursing Center is a 99-bed skilled nursing facility (SNF). The facility is divided into

More information

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control Infection Prevention and Control Annual Report 2009 Produced by: The Director of Infection Prevention and Control Reviewing the period: January 2009 - December 2009 Approved by Infection Control Committee:

More information

Clostridium difficile (C. diff)

Clostridium difficile (C. diff) Patient & Family Guide Clostridium difficile (C. diff) 2017 www.nshealth.ca Clostridium difficile (C. diff) What is C. diff? C. diff is a type of bacteria (germ) that is found in the intestine (gut or

More information

Infection Control. Annual Report 2014 / 15

Infection Control. Annual Report 2014 / 15 Infection Control Annual Report 2014 / 15 July 2015 Report 1. Introduction and Background 1.1 The Trust supports the principle that healthcare acquired infections should be prevented wherever possible

More information

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or

More information

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London Combating Healthcare Associated Infections in the NHS Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London 2007 -The challenge of HCAI MRSA bacteraemia

More information

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE CDI case checklist and standard assessment tool Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE Background to work December 2013, Working Group set up to address concerns about: whether

More information

Infection Prevention and Control. Clostridium difficile Policy

Infection Prevention and Control. Clostridium difficile Policy Infection Prevention and Control Clostridium difficile Policy Policy Title: Clostridium difficile Policy Executive Summary: Clostridium difficile infection is a potentially severe or fatal infection this

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) Approved by: Clostridium difficile Infection (CDI) Vice President and Chief Medical Officer Corporate Policy & Procedures Manual VI-8 Date Approved August 22, 2016 September 16, 2016 Next Review (3 years

More information

Easy read information for patients and visitors. What is clostridium difficile? Clostridium difficile is a germ.

Easy read information for patients and visitors. What is clostridium difficile? Clostridium difficile is a germ. Clostridium difficile Easy read information for patients and visitors What is clostridium difficile? Clostridium difficile is a germ. Clostridium difficile is also known as C diff. A small number of the

More information

Infection Prevention and Control Policy

Infection Prevention and Control Policy Infection Prevention and Control Policy March 2012 Ref: PCD053 (v5) Status: Infection Prevention and Control Policy Policy Reference Number IC017 Status Version 5 Implementation Date September 2007 Current/Last

More information

HSE West, Mid-Western Regional Hospitals, Limerick, Guidelines for The Management of Clostridium Difficile, MGIP&C 09/10, Revision 02, 09/12 pg 1 of

HSE West, Mid-Western Regional Hospitals, Limerick, Guidelines for The Management of Clostridium Difficile, MGIP&C 09/10, Revision 02, 09/12 pg 1 of Clostridium Difficile, MGIP&C 09/10, Revision 02, 09/12 pg 1 of 21 Table of Contents 1.0 POLICY STATEMENT...3 2.0 PURPOSE...3 3.0 SCOPE...3 4.0 LEGISLATION/OTHER RELATED POLICIES...3 5.0 GLOSSARY OF TERMS

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience

More information

Infection Prevention and Control (IPC) Annual Programme 20010/11

Infection Prevention and Control (IPC) Annual Programme 20010/11 Infection Prevention and Control (IPC) Annual Programme 20010/11 1. Introduction The Code of Practice for the Prevention and Control of Healthcare Associated Infections (DH, 2009) otherwise known as the

More information

Preventing Hospital Acquired Infections: Clostridium difficile

Preventing Hospital Acquired Infections: Clostridium difficile Washington State Hospital Association Safe Table Preventing Hospital Acquired Infections: Clostridium difficile January 31, 2017 Lucia Austin-Gil, RN Jessica Symank, RN 2017 Infections Catheter Associated

More information

TRUST BOARD. Date of Meeting: 05/10/2010

TRUST BOARD. Date of Meeting: 05/10/2010 TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling

More information

Infection Prevention and Control Annual Report 1 st April st March 2013

Infection Prevention and Control Annual Report 1 st April st March 2013 Infection Prevention and Control Annual Report 1 st April 2012-31 st March 2013 Patient friendly version Edited by: Fighting Infection Together (FIT) group Table of Contents Section: Page: 1 Introduction

More information

Decreasing Nosocomial C. diff

Decreasing Nosocomial C. diff Decreasing Nosocomial C. diff Our journey to decreasing nosocomial C. diff Jennifer Conti BSN, RN, CIC Nicole Rabic MSN, RN, CIC 4.21.2016 Nosocomial C. diff Use of the CDC standardized definition Review

More information

REPORT SUMMARY SHEET

REPORT SUMMARY SHEET Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 29 th September 2016 Infection Prevention and Control

More information

Montefiore s Clinical Microbiology Lab: Taking Aim at an Urgent Threat

Montefiore s Clinical Microbiology Lab: Taking Aim at an Urgent Threat Montefiore s Clinical Microbiology Lab: Taking Aim at an Urgent Threat Clostridium difficile bacteria. Protecting patients and the community at large from life-threatening microbial pathogens is a mission

More information

INFECTION CONTROL SURVEILLANCE POLICY

INFECTION CONTROL SURVEILLANCE POLICY INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection

More information

CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective

CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective Thank You for Joining! CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective New England Nursing Home Quality Care Collaborative Webinar Will Begin Shortly. Call-In Number: (888)

More information

NHS Highland Infection Prevention & Control Annual Work Plan End of Year

NHS Highland Infection Prevention & Control Annual Work Plan End of Year NHS Highland Board 5 April Item 5.7 NHS Highland & Control Annual Work Plan End of Year Update for COIC Prepared by Catherine Stokoe and Jonty Mills (as of 01/03/) Objective Activity Time Scale Lead Officer

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Michelle Luscombe & Karly Herberholz Hagel 5/14/2012 1 Outline What is clostridium difficile infection (CDI)? Symptoms & Complications Risk Factors Transmission Prevention and Control

More information

Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) Page 1 of 16 Policy Objective To provide HCWs with details of the care required to prevent cross-infection in patients with. This policy applies to all staff employed by NHS Greater Glasgow & Clyde and

More information

INCREASED INCIDENT /OUTBREAK OF DIARRHOEA AND/OR VOMITING

INCREASED INCIDENT /OUTBREAK OF DIARRHOEA AND/OR VOMITING INCREASED INCIDENT /OUTBREAK OF DIARRHOEA AND/OR VOMITING Documentation to support the management of an increased incident or outbreak of Diarrhoea and/or Vomiting including Norovirus Developed by Amanda

More information

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust

More information

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT Rick Catlin 04/04/18 CPE Carbapenemase producing enterobactericae Gut bacteria (enterobactericae) that have developed resistance to multiple

More information

Hospital Acquired Infections

Hospital Acquired Infections Hospital Acquired Infections Hospital acquired infections refer to any infection that occurs during a patient s stay in hospital. They have received a lot of media attention in recent years with increasing

More information

Healthcare Acquired Infections

Healthcare Acquired Infections Healthcare Acquired Infections Emerging Trends in Hospital Administration 9 th & 10 th May 2014 Prof. Hannah Priya HICC In charge What is healthcare acquired infection? An infection occurring in a patient

More information

TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS

TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS Reference Number POL-IC/1079/2011 Old ref no. CL-RM/2014/066 Version 1.2.0 Status Final Author:

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Management of Clostridium difficile Infection (CDI)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Management of Clostridium difficile Infection (CDI) The Newcastle upon Tyne Hospitals NHS Foundation Trust Management of Clostridium difficile Infection (CDI) Version No.: 4.4 Effective From: 30 October 2013 Expiry date: 31 December 2014 Date Ratified:

More information

NHS Greater Glasgow and Clyde Health Board response to allegations concerning Vale of Leven c.diff outbreak

NHS Greater Glasgow and Clyde Health Board response to allegations concerning Vale of Leven c.diff outbreak NHS Greater Glasgow and Clyde Health Board response to allegations concerning Vale of Leven c.diff outbreak 1. Infection-free patients placed into rooms which contain those infected with c.diff It has

More information

Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) Page 1 of 17 Policy Objective To provide HCWs with details of the care required to prevent cross-infection in patients with. This policy applies to all staff employed by NHS Greater Glasgow & Clyde and

More information

Enhanced Surveillance of Clostridium difficile Infection in Ireland

Enhanced Surveillance of Clostridium difficile Infection in Ireland Enhanced Surveillance of Clostridium difficile Infection in Ireland Protocol for Completion of Enhanced Surveillance Information Version 3.5, July 2014 Table of Contents BACKGROUND... 2 METHODOLOGY...

More information

Infection Prevention and Control Operational Policy

Infection Prevention and Control Operational Policy Infection Prevention and Control Operational Policy Author(s) Vickie Longstaff (Infection Control Nurse Consultant) Version 7 (Updated from January 2011 version) Version Date February 2012 Implementation/approval

More information

Trust Standard for the Assessment and Management of Physical Health Practice Guidance Note Enteral Tube Feeding Overview V01

Trust Standard for the Assessment and Management of Physical Health Practice Guidance Note Enteral Tube Feeding Overview V01 Trust Standard for the Assessment and Management of Physical Health Practice Guidance Note Enteral Tube Feeding Overview V01 Date Issued Planned Review PGN No: Issue 1 Aug 16 Issue 2 Nov 16 Aug 19 AMPH-PGN-02

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012 C SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012 Subject: C.difficile Action Plan 2012/2013 Supporting Director: Professor Hilary Chapman, Chief Nurse/Chief

More information

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION Compliance 1) Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible

More information

Investigation into the two outbreaks of Clostridium difficile at Stoke Mandeville Hospital between October 2003 and June 2005

Investigation into the two outbreaks of Clostridium difficile at Stoke Mandeville Hospital between October 2003 and June 2005 Monday 24 July - for immediate release Investigation into the two outbreaks of Clostridium difficile at Stoke Mandeville Hospital between October 2003 and June 2005 The Healthcare Commission s report into

More information

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) Reference Number POL- IC/1082/14 Version 1.2.0 Status Final Author: Helen Forrest

More information

Learning Objectives. Successful Antibiotic Stewardship. Byron Health Center & GrandView Pharmacy

Learning Objectives. Successful Antibiotic Stewardship. Byron Health Center & GrandView Pharmacy Successful Antibiotic Stewardship Byron Health Center & GrandView Pharmacy Learning Objectives Understand the core requirements of an antibiotic stewardship program as defined by the CMS Requirements of

More information